VYYRF (Voyageur Pharmaceuticals) EV-to-Revenue : (As of May. 29, 2025)

Voyageur Pharmaceuticals EV-to-Revenue Chart

Voyageur Pharmaceuticals Annual Data
	Trend	Dec15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23	Nov24
EV-to-Revenue		Get a 7-Day Free Trial					-	-	-	-	-

Voyageur Pharmaceuticals Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Voyageur Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Voyageur Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's EV-to-Revenue falls into.

Voyageur Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Voyageur Pharmaceuticals's EV-to-Revenue for today is calculated as:

Voyageur Pharmaceuticals's current Enterprise Value is $19.53 Mil.
Voyageur Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals  (OTCPK:VYYRF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Voyageur Pharmaceuticals's PS Ratiofor today is calculated as:

Voyageur Pharmaceuticals's share price for today is $0.10.
Voyageur Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description